-
1
-
-
0033540646
-
Sexual dysfunction in the United States: Prevalence and predictors
-
Laumann E.O., Paik A., Rosen R.C. Sexual dysfunction in the United States prevalence and predictors . JAMA. 281:1999;537-544.
-
(1999)
JAMA
, vol.281
, pp. 537-544
-
-
Laumann, E.O.1
Paik, A.2
Rosen, R.C.3
-
2
-
-
0012412583
-
Management of the changing vagina
-
Notelovitz M. Management of the changing vagina. J Clin Pract Sexual. 16:(Special Issue):1990;7.
-
(1990)
J Clin Pract Sexual
, vol.16
, Issue.SPEC. ISSUE
, pp. 7
-
-
Notelovitz, M.1
-
3
-
-
0003211799
-
The impact of vaginal health on sexual function
-
Bachmann G.A. The impact of vaginal health on sexual function. J Clin Pract Sexual. Special Issue:1990;18-21.
-
(1990)
J Clin Pract Sexual
, Issue.SPEC. ISSUE
, pp. 18-21
-
-
Bachmann, G.A.1
-
4
-
-
0031429048
-
Outcomes of hysterectomy
-
Carlson K.J. Outcomes of hysterectomy. Clinic Obstet Gynecol. 40:1997;939-946.
-
(1997)
Clinic Obstet Gynecol
, vol.40
, pp. 939-946
-
-
Carlson, K.J.1
-
5
-
-
0025273637
-
Sexuality and menopause
-
Sarrel P.M. Sexuality and menopause. Obstet Gynecol. 75:1990;26S-30S.
-
(1990)
Obstet Gynecol
, vol.75
-
-
Sarrel, P.M.1
-
6
-
-
0031805041
-
Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral erectile insufficiency syndromes
-
Goldstein I., Berman J.R. Vasculogenic female sexual dysfunction vaginal engorgement and clitoral erectile insufficiency syndromes . Int J Impot Res. 10:(Suppl 2):1998;S84-90.
-
(1998)
Int J Impot Res
, vol.10
, Issue.SUPPL. 2
, pp. 84-90
-
-
Goldstein, I.1
Berman, J.R.2
-
7
-
-
0026430787
-
Management of vaginal dryness
-
Key E., Smith S. Management of vaginal dryness. Nurs Stand. 5:1991;24-27.
-
(1991)
Nurs Stand
, vol.5
, pp. 24-27
-
-
Key, E.1
Smith, S.2
-
8
-
-
0031754497
-
Receptors for purines and pyrimidines
-
Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 50:1998;413-492.
-
(1998)
Pharmacol Rev
, vol.50
, pp. 413-492
-
-
Ralevic, V.1
Burnstock, G.2
-
9
-
-
0035040885
-
Therapeutic use of nucleotides in respiratory and ophthalmic diseases
-
Yerxa B.R. Therapeutic use of nucleotides in respiratory and ophthalmic diseases. Drug Develop Res. 52:2001;196-201.
-
(2001)
Drug Develop Res
, vol.52
, pp. 196-201
-
-
Yerxa, B.R.1
-
10
-
-
0029006763
-
Biphasic regulation of paracellular permeability in human cervical cells by two distinct nucleotide receptors
-
Gorodeski G.I., Hopfer U., De Santis B.J., Eckert R.L., Rorke E.A., Utian W.H. Biphasic regulation of paracellular permeability in human cervical cells by two distinct nucleotide receptors. Am J Physiol. 268:1995;C1215-1226.
-
(1995)
Am J Physiol
, vol.268
, pp. 1215-1226
-
-
Gorodeski, G.I.1
Hopfer, U.2
De Santis, B.J.3
Eckert, R.L.4
Rorke, E.A.5
Utian, W.H.6
-
11
-
-
0036079412
-
Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms
-
Gorodeski G.I. Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms. Am J Physiol Cell Physiol. 282:2002;C75-83.
-
(2002)
Am J Physiol Cell Physiol
, vol.282
, pp. 75-83
-
-
Gorodeski, G.I.1
-
12
-
-
0035090288
-
The amount of MUC5B mucin in cervical mucus peaks at midcycle
-
Gipson I.K., Moccia R., Spurr-Michaud S., Argueso P., Gargiulo A.R., Hill J.A. 3rd, et al. The amount of MUC5B mucin in cervical mucus peaks at midcycle. J Clin Endocrinol Metab. 86:2001;594-600.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 594-600
-
-
Gipson, I.K.1
Moccia, R.2
Spurr-Michaud, S.3
Argueso, P.4
Gargiulo, A.R.5
Hill III J.A. 6
-
13
-
-
0002335322
-
2 agonist, INS365: A potential dry eye therapeutic agent
-
2 agonist, INS365 a potential dry eye therapeutic agent . Cornea. 19:(Suppl 2):2000;S87.
-
(2000)
Cornea
, vol.19
, Issue.SUPPL. 2
, pp. 87
-
-
Fujihara, T.1
Murakami, T.2
Fujita, H.3
Nakamura, M.4
Nakata, K.5
-
15
-
-
0031702541
-
Tibolone prevents atheroslerosic lesion formation in cholesterol-fed ovariectomized rabbits
-
Zandberg P., Peters J.L., Demacker P.N., Smit M.J., de Reeder E.G., Meuleman D.G. Tibolone prevents atheroslerosic lesion formation in cholesterol-fed ovariectomized rabbits. Arterioscler Thromb Vasc Biol. 18:1998;1844-1854.
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1844-1854
-
-
Zandberg, P.1
Peters, J.L.2
Demacker, P.N.3
Smit, M.J.4
De Reeder, E.G.5
Meuleman, D.G.6
-
16
-
-
0032863823
-
2 receptor agonists: Structure, activity and therapeutic utility
-
2 receptor agonists structure, activity and therapeutic utility . Drugs Future. 24:1999;759-769.
-
(1999)
Drugs Future
, vol.24
, pp. 759-769
-
-
Yerxa, B.R.1
Johnson, F.L.2
-
17
-
-
0036188807
-
Changes in proinflammatory cytokine activity after menopause
-
Pfeilschifter J., Koditz R., Pfohl M., Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 23:2002;90-119.
-
(2002)
Endocr Rev
, vol.23
, pp. 90-119
-
-
Pfeilschifter, J.1
Koditz, R.2
Pfohl, M.3
Schatz, H.4
-
18
-
-
0033932331
-
Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract
-
Kaushic C., Ahou F., Murdin A.D., Wira C.R. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect Immun. 68:2000;4207-4216.
-
(2000)
Infect Immun
, vol.68
, pp. 4207-4216
-
-
Kaushic, C.1
Ahou, F.2
Murdin, A.D.3
Wira, C.R.4
-
19
-
-
0035884893
-
17β-Estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis
-
Matejuk A., Adlard K., Zamora A., Silverman M., Vandenbark A.A., Offner H. 17β-Estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res. 65:2001;529-542.
-
(2001)
J Neurosci Res
, vol.65
, pp. 529-542
-
-
Matejuk, A.1
Adlard, K.2
Zamora, A.3
Silverman, M.4
Vandenbark, A.A.5
Offner, H.6
|